Published in J Neurol Sci on August 01, 1985
Blood-brain barrier dysfunction as a cause and consequence of Alzheimer's disease. J Cereb Blood Flow Metab (2013) 1.45
Proteomics-derived cerebrospinal fluid markers of autopsy-confirmed Alzheimer's disease. Biomarkers (2009) 0.97
Focal cerebral hypoperfusion and selective cognitive deficit in dementia of the Alzheimer type. J Neurol Neurosurg Psychiatry (1987) 0.90
Catalytic antibodies to amyloid beta peptide in defense against Alzheimer disease. Autoimmun Rev (2008) 0.84
Integrity of the blood-CSF barrier in dementia of Alzheimer type: CSF/serum ratios of albumin and IgG. Eur Arch Psychiatry Clin Neurosci (1991) 0.83
Beneficial catalytic immunity to abeta peptide. Rejuvenation Res (2010) 0.75
Difference in toxicity of beta-amyloid peptide with aging in relation to nerve growth factor content in rat brain. J Neural Transm (Vienna) (2001) 0.75
Blood-Brain Barrier Dysfunction and the Pathogenesis of Alzheimer's Disease. Int J Mol Sci (2017) 0.75
Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology (1993) 16.92
Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med (2004) 16.58
A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke (2001) 5.81
Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease. Neuroepidemiology (1998) 2.83
Incident lacunes influence cognitive decline: the LADIS study. Neurology (2011) 2.81
Association of gait and balance disorders with age-related white matter changes: the LADIS study. Neurology (2008) 2.41
Small-vessel disease relates to poor poststroke survival in a 12-year follow-up. Neurology (2011) 2.19
White matter hyperintensities on MRI in the neurologically nondiseased elderly. Analysis of cohorts of consecutive subjects aged 55 to 85 years living at home. Stroke (1995) 2.01
White matter changes in healthy elderly persons correlate with attention and speed of mental processing. Arch Neurol (1993) 1.86
CT and MRI rating of white matter lesions. Cerebrovasc Dis (2002) 1.83
Genetic susceptibility to multiple sclerosis linked to myelin basic protein gene. Lancet (1992) 1.79
Short Portable Mental Status Questionnaire as a screening test for dementia and delirium among the elderly. J Am Geriatr Soc (1987) 1.76
Corpus callosum atrophy as a predictor of age-related cognitive and motor impairment: a 3-year follow-up of the LADIS study cohort. J Neurol Sci (2011) 1.66
Prevalence of severe dementia in Finland. Neurology (1985) 1.62
Interferon regulatory factor 5 (IRF5) gene variants are associated with multiple sclerosis in three distinct populations. J Med Genet (2008) 1.59
Abundant expression of HIV Nef and Rev proteins in brain astrocytes in vivo is associated with dementia. AIDS (1995) 1.59
Depression is an independent predictor of poor long-term functional outcome post-stroke. Eur J Neurol (2001) 1.59
Accuracy of clinical diagnosis in primary degenerative dementia: correlation with neuropathological findings. J Neurol Neurosurg Psychiatry (1983) 1.59
Genomewide scan of multiple sclerosis in Finnish multiplex families. Am J Hum Genet (1997) 1.57
Dementia three months after stroke. Baseline frequency and effect of different definitions of dementia in the Helsinki Stroke Aging Memory Study (SAM) cohort. Stroke (1997) 1.56
Moderate alcohol consumption and loss of cerebellar Purkinje cells. BMJ (1994) 1.53
White matter lesion progression: a surrogate endpoint for trials in cerebral small-vessel disease. Neurology (2004) 1.47
The significance of medial temporal lobe atrophy: a postmortem MRI study in the very old. Neurology (2007) 1.46
Raised plasma endothelin during acute migraine attack. Cephalalgia (1992) 1.45
White matter changes and diabetes predict cognitive decline in the elderly: the LADIS study. Neurology (2010) 1.44
Clinical determinants of poststroke dementia. Stroke (1998) 1.36
Do white matter changes on MRI and CT differentiate vascular dementia from Alzheimer's disease? J Neurol Neurosurg Psychiatry (1987) 1.36
Variable agreement between visual rating scales for white matter hyperintensities on MRI. Comparison of 13 rating scales in a poststroke cohort. Stroke (1997) 1.33
White matter changes and late-life depressive symptoms: longitudinal study. Br J Psychiatry (2007) 1.31
Studies on the clustering of multiple sclerosis in Finland I: Comparison between the domiciles and places of birth in selected subpopulations. Acta Neurol Scand (1975) 1.29
White matter changes in stroke patients. Relationship with stroke subtype and outcome. Eur Neurol (1999) 1.29
Demonstration of fibronectin in human cerebrospinal fluid. J Lab Clin Med (1978) 1.28
Diagnosis and management of brain death. Br Med J (1979) 1.28
Deep frontal and periventricular age related white matter changes but not basal ganglia and infratentorial hyperintensities are associated with falls: cross sectional results from the LADIS study. J Neurol Neurosurg Psychiatry (2009) 1.28
Executive functions and speed of mental processing in elderly patients with frontal or nonfrontal ischemic stroke. Eur J Neurol (1999) 1.27
Meta-analysis of the Hachinski Ischemic Score in pathologically verified dementias. Neurology (1997) 1.27
Vascular dementia due to cardiac arrhythmias and systemic hypotension. Acta Neurol Scand (1987) 1.27
Dementia among medical inpatients. Evaluation of 2000 consecutive admissions. Arch Intern Med (1986) 1.27
Classic amyotrophic lateral sclerosis with dementia. Arch Neurol (1982) 1.26
Amyloid protein in familial amyloidosis (Finnish type) is homologous to gelsolin, an actin-binding protein. Biochem Biophys Res Commun (1990) 1.25
Diabetes mellitus, hypertension and medial temporal lobe atrophy: the LADIS study. Diabet Med (2007) 1.25
White matter hyperintensities as a predictor of neuropsychological deficits post-stroke. J Neurol Neurosurg Psychiatry (2005) 1.24
Multicentre, randomised, double blind, placebo controlled, phase III study of weekly, low dose, subcutaneous interferon beta-1a in secondary progressive multiple sclerosis. J Neurol Neurosurg Psychiatry (2004) 1.24
Frontal lobe white matter hyperintensities and neurofibrillary pathology in the oldest old. Neurology (2010) 1.22
Poststroke depression and lesion location revisited. J Neuropsychiatry Clin Neurosci (2004) 1.21
Frequency and clinical determinants of poststroke depression. Stroke (1998) 1.20
Accuracy of the clinical diagnosis of vascular dementia: a prospective clinical and post-mortem neuropathological study. J Neurol Neurosurg Psychiatry (1988) 1.19
EFNS-ENS Guidelines on the diagnosis and management of disorders associated with dementia. Eur J Neurol (2012) 1.19
Reliability and sensitivity of visual scales versus volumetry for evaluating white matter hyperintensity progression. Cerebrovasc Dis (2008) 1.17
Brain atrophy accelerates cognitive decline in cerebral small vessel disease: the LADIS study. Neurology (2012) 1.17
Cognitive profile of subcortical ischaemic vascular disease. J Neurol Neurosurg Psychiatry (2006) 1.16
Amyloid in familial amyloidosis, Finnish type, is antigenically and structurally related to gelsolin. Am J Pathol (1990) 1.16
Realistic expectations for treatment success in Alzheimer's disease. J Nutr Health Aging (2006) 1.15
Post-stroke depression, executive dysfunction and functional outcome. Eur J Neurol (2002) 1.10
Simple versus complex assessment of white matter hyperintensities in relation to physical performance and cognition: the LADIS study. J Neurol (2006) 1.10
How complex interactions of ischemic brain infarcts, white matter lesions, and atrophy relate to poststroke dementia. Arch Neurol (2000) 1.09
Intercellular adhesion molecule-1 K/E 469 polymorphism and multiple sclerosis. Ann Neurol (1999) 1.09
Regional and temporal variation in the incidence of multiple sclerosis in Finland 1979-1993. Neuroepidemiology (2000) 1.08
Role of white matter lesions in cognitive impairment of vascular origin. Alzheimer Dis Assoc Disord (2000) 1.08
Aspartylglycosaminuria: a gargoyle-like syndrome with autosomal recessive inheritance. Birth Defects Orig Artic Ser (1974) 1.07
Diagnosis of vascular dementia: Consortium of Canadian Centres for Clinical Cognitive Research concensus statement. Can J Neurol Sci (1994) 1.06
Insomnia in ischemic stroke patients. Cerebrovasc Dis (2002) 1.06
Immunoregulatory factors in multiple sclerosis patients during and after pregnancy: relevance of natural killer cells. Clin Exp Immunol (2007) 1.05
Immunocytochemical studies of Alzheimer neuronal perikarya with intermediate filament antisera. J Neurol Sci (1983) 1.04
Clinical significance of corpus callosum atrophy in a mixed elderly population. Neurobiol Aging (2006) 1.04
Functional assessment scales in detecting dementia. Age Ageing (1997) 1.04
End of life decisions: attitudes of Finnish physicians. J Med Ethics (2004) 1.04
Two-locus linkage analysis in multiple sclerosis (MS). Genomics (1994) 1.03
Correction for age, education and other demographic variables in the use of the Mini Mental State Examination in Finland. Acta Neurol Scand (1992) 1.02
Magnetic resonance imaging white matter hyperintensities and mechanism of ischemic stroke. Stroke (1999) 1.01
Biochemical and fine structural studies on brain and liver biopsies in aspartylglucosaminuria. Neurology (1971) 1.01
Relationship between baseline white-matter changes and development of late-life depressive symptoms: 3-year results from the LADIS study. Psychol Med (2009) 1.01
CSF beta-endorphin and beta-lipotropin in Alzheimer's disease and multi-infarct dementia. Neurology (1985) 0.99
Low prevalence of Huntington's disease in Finland. Lancet (1987) 0.99
Magnetic resonance imaging correlates of depression after ischemic stroke. Arch Gen Psychiatry (2001) 0.99
Two patients with a 46,XX,Er chromosome constitution. Acta Paediatr Scand (1968) 0.99
Occupations with exposure to electromagnetic fields: a possible risk factor for Alzheimer's disease. Am J Epidemiol (1995) 0.98
White matter changes contribute to corpus callosum atrophy in the elderly: the LADIS study. AJNR Am J Neuroradiol (2008) 0.97
MRI correlates of executive dysfunction in patients with ischaemic stroke. Eur J Neurol (2003) 0.97
Major depression in the elderly: a population study in Helsinki. Int Psychogeriatr (1996) 0.97
Postural hypotension and dizziness in a general aged population: a four-year follow-up of the Helsinki Aging Study. J Am Geriatr Soc (1996) 0.96
Neuronal intranuclear inclusion disease in identical twins. Ann Neurol (1984) 0.96
Association between salivary flow rate and the use of systemic medication among 76-, 81-, and 86-year-old inhabitants in Helsinki, Finland. J Dent Res (1992) 0.96
The mid-M1 segment of the middle cerebral artery is a cutoff clot location for good outcome in intravenous thrombolysis. Eur J Neurol (2012) 0.96
Increasing prevalence of multiple sclerosis in Finland. Acta Neurol Scand (2001) 0.96
Medial temporal lobe atrophy and white matter hyperintensities are associated with mild cognitive deficits in non-disabled elderly people: the LADIS study. J Neurol Neurosurg Psychiatry (2005) 0.96
Comparison of stroke features and disability in daily life in patients with ischemic stroke aged 55 to 70 and 71 to 85 years. Stroke (1997) 0.96
Eleven new cases of aspartylglucosaminuria. J Ment Defic Res (1970) 0.95
DARS2 mutations in mitochondrial leucoencephalopathy and multiple sclerosis. J Med Genet (2009) 0.94
Snoring, sleep apnea syndrome, and stroke. Neurology (1992) 0.94
Neuropsychological differentiation between normal aging, Alzheimer's disease and vascular dementia. Acta Neurol Scand (1986) 0.93
Toward understanding the pathogenic mechanisms in gelsolin-related amyloidosis: in vitro expression reveals an abnormal gelsolin fragment. Hum Mol Genet (1994) 0.93
MRI of the brain in neurologically healthy middle-aged and elderly individuals. Neuroradiology (1997) 0.92
Cognitive impairment predicts poststroke death in long-term follow-up. J Neurol Neurosurg Psychiatry (2009) 0.92
High levels of brain dolichols in neuronal ceroid-lipofuscinosis and senescence. J Neurochem (1983) 0.92